Broadleaf Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-82,305
| Closed | -$9.33M | – | 81 |
|
|
2024
Q2 | $9.33M | Sell |
82,305
-507
| -0.6% | -$57.5K | 2.26% | 17 |
|
|
2024
Q1 | $11.5M | Buy |
82,812
+1,010
| +1% | +$140K | 2.94% | 10 |
|
|
2023
Q4 | $10.2M | Sell |
81,802
-2,110
| -3% | -$262K | 2.98% | 10 |
|
|
2023
Q3 | $7.83M | Buy |
83,912
+24,642
| +42% | +$2.3M | 2.61% | 15 |
|
|
2023
Q2 | $7.62M | Buy |
+59,270
| New | +$7.62M | 2.49% | 15 |
|
|
2022
Q2 | – | Sell |
-33,016
| Closed | -$4.22M | – | 66 |
|
|
2022
Q1 | $4.22M | Buy |
+33,016
| New | +$4.22M | 1.41% | 30 |
|